Manufacturing Methods for Liposome Adjuvants


Authors: Y. Perrie, E. Kastner, S. Khadke, C. Roces and P. Stone

Journal: Vaccine Adjuvants

DOI: https://dx.doi.org/10.1007/978-1-4939-6445-1_9

Publication - Abstract

October 08, 2016

Diagnostic and Imaging Liposomes Vaccines

Abstract:

A wide range of studies have shown that liposomes can act as suitable adjuvants for a range of vaccine antigens. Properties such as their amphiphilic character and biphasic nature allow them to incorporate antigens within the lipid bilayer, on the surface, or encapsulated within the inner core. However, appropriate methods for the manufacture of liposomes are limited and this has resulted in issues with cost, supply, and wider scale application of these systems. Within this chapter we explore manufacturing processes that can be used for the production of liposomal adjuvants, and we outline new manufacturing methods can that offer fast, scalable, and cost-effective production of liposomal adjuvants.


limit search to this category
Advanced Search

Advanced Search

close
  • Publications
  • Application Notes
  • Posters
  • Workshops
  • Videos & Webinars
  • Articles
Search

Browse by Category

  • Application
    • Diagnostic and Imaging
    • Genetic Medicine
    • Hematology
    • Metabolic Disorders
    • Neuroscience
    • Oncology
    • Skeletal Disorders
    • Targeted Drug Delivery
    • Vaccines
    • Other Applications
    • Cell therapy
  • Formulation
    • Liposomes
    • Nucleic Acid Lipid Nanoparticles
    • Polymeric Nanoparticles
    • Other Formulations
  • Payload
    • DNA
    • microRNA
    • mRNA
    • siRNA
    • Small Molecule Drugs
    • Other Payloads


related content

Publication - Abstract

Jun 03, 2019
Journal of Controlled Release

Formulation and Manufacturing of Lymphatic Targeting Liposomes Using Microfluidics

S. Khakde, C.B. Roces, A. Cameron, A Devit and Y. Perrie

Oncology Vaccines Liposomes

The lymphatics are a target for a range of therapeutic purposes, including cancer therapy and vaccination and both vesicle size and charge have been considered as factors controlling lymphatic targeting. Within this work, a range...

Read More


Publication - Summary

Jan 14, 2019
Cancer Immunology, Immunotherapy

STAT3 Inhibition Specifically in Human Monocytes and Macrophages by CD163-targeted Corosolic Acid-containing Liposomes

M.N. Andersen, A. Etzerodt, J.H. Graversen, L.C. Holthof, S.K. Moestrup, M. Hokland and H.J. Møller

Targeted Drug Delivery Liposomes Small Molecule Drugs
Researchers from Holger J. Møller's group at Aarhus University in Denmark have published an approach to a cancer immunotherapy that involves altering the function of tumour associated macrophages (TAMs) to fight cancer.  TAMs can take on two main phenotypes: the tumou...
Read More


Sign Up and Stay Informed
Sign up today to automatically receive new Cytiva, formerly Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.
Sign Up